UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial

Hepatology international, 2021-12, Vol.15 (6), p.1402-1412

2021

Link zum Volltext

Verfügbarkeit prüfen

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B

Journal of hepatology, 2010-03, Vol.52 (3), p.330-339

2010

Link zum Volltext

Verfügbarkeit prüfen

Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

Hepatology international, 2023-08, Vol.17 (4), p.850-859

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC

Hepatology communications, 2022-04, Vol.6 (4), p.841-854

2022

Link zum Volltext

Verfügbarkeit prüfen

273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantation

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A298-A298

2020

Link zum Volltext

Verfügbarkeit prüfen

Immune Response in Hepatitis B Virus Infection

Cold Spring Harbor perspectives in medicine, 2015-08, Vol.5 (8), p.a021428-a021428

2015

Link zum Volltext

Verfügbarkeit prüfen

Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection

PloS one, 2011-08, Vol.6 (8), p.e23330-e23330

2011

Link zum Volltext

Verfügbarkeit prüfen

Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection

The Journal of clinical investigation, 2017-08, Vol.127 (8), p.3177-3188

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer immunotherapy: Targeting the difference

Journal of hepatology, 2014-11, Vol.61 (5), p.1175-1177

2014

Link zum Volltext

Verfügbarkeit prüfen

T-cell therapy for chronic viral hepatitis

Cytotherapy (Oxford, England), 2017-11, Vol.19 (11), p.1317-1324

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future

Diseases, 2016-02, Vol.4 (1), p.10

2016

Link zum Volltext

Verfügbarkeit prüfen

Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?

Medical microbiology and immunology, 2015-02, Vol.204 (1), p.87-94

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1862-1876.e9

2019

Link zum Volltext

Verfügbarkeit prüfen

Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3

Gastroenterology (New York, N.Y. 1943), 2018-07, Vol.155 (1), p.180-193.e6

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppressive Drug‐Resistant Armored T‐Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients

Hepatology (Baltimore, Md.), 2021-07, Vol.74 (1), p.200-213

2021

Link zum Volltext

Verfügbarkeit prüfen

Redirecting T Cell Specificity Using T Cell Receptor Messenger RNA Electroporation

Methods in molecular biology (Clifton, N.J.), 2016, Vol.1428, p.285

2016

Link zum Volltext

Verfügbarkeit prüfen

A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors

JCI insight, 2017-06, Vol.2 (12)

2017

Link zum Volltext

Verfügbarkeit prüfen

Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

Journal of hepatology, 2011-07, Vol.55 (1), p.103-110

2011

Link zum Volltext

Verfügbarkeit prüfen

PS-141-CyTOF-based immune monitoring of HBV-HCC patients receiving autologous anti-tumour T-cell therapy

Journal of hepatology, 2019-04, Vol.70 (1), p.e89-e90

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties

Journal of virology, 2017-05, Vol.91 (9)

2017

Link zum Volltext

Verfügbarkeit prüfen

Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective

Journal of gastroenterology and hepatology, 2008-06, Vol.23 (6), p.833-843

2008

Link zum Volltext

Verfügbarkeit prüfen

Immune Response During Hepatitis B Virus Infection and Reconstitution of HBV-Specific Immunity Using T Cells Redirected Against HBV

Koh, Sarene

2013

Link zum Volltext
ProQuest

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3

Journal of general virology, 2012-02, Vol.93 (Pt 2), p.247-258

2012

Link zum Volltext

Verfügbarkeit prüfen

Viral hepatitis and serotonin: altering cytotoxic T-lymphocyte function in the liver

Expert review of vaccines, 2009-01, Vol.8 (1), p.29-32

2009

Link zum Volltext

Verfügbarkeit prüfen

Improving on the Ability of Endogenous Hepatitis B Core Antigen to Prime Cytotoxic T Lymphocytes

The Journal of infectious diseases, 2010-06, Vol.201 (12), p.1867-1879

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)
Dissertationen
(1)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Humans
(16)
Gastroenterology & Hepatology
(10)
Hepatitis B Virus - Immunology
(9)
Immunotherapy
(8)
Hepatitis B
(7)
Hepatitis B Virus
(7)
Lymphocytes
(7)
Medicin Och Hälsovetenskap
(7)
Receptors, Antigen, T-Cell - Genetics
(7)
T Cell Receptors
(7)
T-Lymphocytes - Immunology
(7)
Viruses
(7)
Hepatitis B, Chronic - Immunology
(6)
Patients
(6)
Animals
(5)
Biological And Medical Sciences
(5)
Electroporation
(5)
Hepatocytes
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(4)
Gastroenterology
(2)
Hepatology International
(2)
Cold Spring Harbor Perspectives In Medicine
(1)
Cytotherapy
(1)
Diseases
(1)
Expert Review Of Vaccines
(1)
Hepatology
(1)
Hepatology Communications
(1)
Jci Insight
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B

Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC

273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantation

Immune Response in Hepatitis B Virus Infection

Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection

Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection

Cancer immunotherapy: Targeting the difference

T-cell therapy for chronic viral hepatitis

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future

Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?

Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy

Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3

Immunosuppressive Drug‐Resistant Armored T‐Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients

Redirecting T Cell Specificity Using T Cell Receptor Messenger RNA Electroporation

A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors

Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

PS-141-CyTOF-based immune monitoring of HBV-HCC patients receiving autologous anti-tumour T-cell therapy

Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties

Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective

Immune Response During Hepatitis B Virus Infection and Reconstitution of HBV-Specific Immunity Using T Cells Redirected Against HBV

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3

Viral hepatitis and serotonin: altering cytotoxic T-lymphocyte function in the liver

Improving on the Ability of Endogenous Hepatitis B Core Antigen to Prime Cytotoxic T Lymphocytes

Suchergebnisse filtern